Free tool
FAERS Monitor: Anafranil
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019906 or its brand name (Anafranil, Clomipramine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
4,574
Serious
4,205
92% of reports
Hospitalization
2,459
Death reported
402
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug interaction234
- somnolence217
- fall209
- off label use200
- tremor189
- nausea182
- coma180
- suicide attempt177
- intentional overdose176
- drug ineffective173
- anxiety167
- confusional state166
- malaise152
- asthenia151
- fatigue148
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 168 |
| 2005 | 121 |
| 2006 | 118 |
| 2007 | 139 |
| 2008 | 156 |
| 2009 | 153 |
| 2010 | 161 |
| 2011 | 192 |
| 2012 | 180 |
| 2013 | 169 |
| 2014 | 199 |
| 2015 | 221 |
| 2016 | 257 |
| 2017 | 261 |
| 2018 | 290 |
| 2019 | 304 |
| 2020 | 291 |
| 2021 | 190 |
| 2022 | 206 |
| 2023 | 248 |
| 2024 | 210 |
| 2025 | 169 |
| 2026 | 170 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,585 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| comaSignal | 180 | 17.4 | 15.1 | 2,770 |
| suicide attemptSignal | 177 | 13.5 | 11.6 | 2,029 |
| intentional overdoseSignal | 176 | 12.7 | 10.9 | 1,877 |
| drug interactionSignal | 234 | 6.8 | 6.0 | 1,157 |
| tremorSignal | 189 | 5.2 | 4.6 | 649 |
| somnolenceSignal | 217 | 5.0 | 4.4 | 688 |
| confusional stateSignal | 166 | 4.7 | 4.1 | 487 |
| fallSignal | 209 | 2.9 | 2.5 | 260 |
| anxietySignal | 167 | 2.7 | 2.3 | 179 |
| asthenia | 151 | 1.8 | 1.6 | 59 |
| malaise | 152 | 1.6 | 1.4 | 34 |
| nausea | 182 | 1.1 | 0.9 | 1 |
| off label use | 200 | 1.1 | 0.9 | 0 |
| fatigue | 148 | 0.9 | 0.7 | 3 |
| drug ineffective | 173 | 0.6 | 0.5 | 48 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.